Biologic Drugs To Drive Pharmaceutical Market Growth - Biologics Market Research

Biologic Drugs To Drive Pharmaceutical Market Growth
Published Date: October 2006
Published By: Datamonitor
Page Count: 9
Order Code: R313-17543
Price: $1695 Online Download
$3390 Global Site License
Introduction
As patent expiries take their toll on small molecule blockbuster drugs Big Pharma are turning to biologic therapies to drive future growth. Alliances and partnerships will be a key strategy in gaining access to the technology needed to successfully penetrate this market
Scope
An overview of Datamonitor's forecasts for the biologic therapy sales of the leading pharmaceutical companies
Discussion of the leading Big Pharma players operating in this area
A review of the evolution in antibody engineering which is currently driving the growth of this area
Highlights
Biologic therapies will drive the majority of the Big Pharma companies sales growth to 2010, based on Datamonitor's forecasts. Of these therapies monoclonal antibodies will be the key sales drivers.
Reasons to Purchase
Benchmark the presence of the Big Pharma companies in the biologics market place
Assess the key strategies that companies are using to gain access to the necessary technologies